Literature DB >> 20378660

A UK validation of the Stages of Recovery Instrument.

Gavin Weeks1, Mike Slade, Mark Hayward.   

Abstract

OBJECTIVE: There is considerable interest in the concept of recovery from psychosis. Consumers describe recovery as a process as opposed to a clinical outcome. However, measures of recovery have an important role in the development of recovery-based mental health services. This study sought to investigate the validity and reliability of the Stages of Recovery Instrument (STORI) (Andresen et al., 2006). This is an Australian instrument chosen as a promising measure of recovery developed from the perspectives of consumer accounts.
METHOD: A questionnaire design was used to investigate the following aspects of validity: face validity and feasibility; concurrent validity; construct validity; and test-retest reliability. Fifty (50) people from the caseloads of three specialist mental health teams in a London borough completed the STORI, the Recovery Assessment Scale (RAS) (Corrigan et al., 1999) and a feedback questionnaire. Twenty two (22) people completed the STORI a second time for the purposes of test-retest reliability exploration.
RESULTS: Participants' responses to the feedback questionnaire were mainly positive. This was seen as evidence of face validity and feasibility. Correlations between the STORI and the RAS provided evidence of concurrent validity. Cluster analysis revealed that the STORI items formed three clusters rather than five. Strong correlations between the first and second STORI administrations provided initial evidence for the test-retest reliability.
CONCLUSIONS: The STORI can be used to measure recovery concepts in the UK. However, it does not measure the five-stage model on which it was based. A three-stage model of recovery might best form the basis of future recovery research.

Entities:  

Mesh:

Year:  2010        PMID: 20378660     DOI: 10.1177/0020764010365414

Source DB:  PubMed          Journal:  Int J Soc Psychiatry        ISSN: 0020-7640


  10 in total

1.  Courses of helping alliance in the treatment of people with severe mental illness in Europe: a latent class analytic approach.

Authors:  Sabine Loos; Katrin Arnold; Mike Slade; Harriet Jordan; Valeria Del Vecchio; Gaia Sampogna; Ágnes Süveges; Marietta Nagy; Malene Krogsgaard Bording; Helle Østermark Sørensen; Wulf Rössler; Wolfram Kawohl; Bernd Puschner
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-09-23       Impact factor: 4.328

2.  The DUNDRUM Quartet: validation of structured professional judgement instruments DUNDRUM-3 assessment of programme completion and DUNDRUM-4 assessment of recovery in forensic mental health services.

Authors:  Sarah O'Dwyer; Mary Davoren; Zareena Abidin; Elaine Doyle; Kim McDonnell; Harry G Kennedy
Journal:  BMC Res Notes       Date:  2011-07-03

3.  The development and evaluation of a five-language multi-perspective standardised measure: clinical decision-making involvement and satisfaction (CDIS).

Authors:  Mike Slade; Harriet Jordan; Eleanor Clarke; Paul Williams; Helena Kaliniecka; Katrin Arnold; Andrea Fiorillo; Domenico Giacco; Mario Luciano; Anikó Égerházi; Marietta Nagy; Malene Krogsgaard Bording; Helle Østermark Sørensen; Wulf Rössler; Wolfram Kawohl; Bernd Puschner
Journal:  BMC Health Serv Res       Date:  2014-07-28       Impact factor: 2.655

4.  Recovery and decision-making involvement in people with severe mental illness from six countries: a prospective observational study.

Authors:  Sabine Loos; Eleanor Clarke; Harriet Jordan; Bernd Puschner; Andrea Fiorillo; Mario Luciano; Tibor Ivánka; Erzsébet Magyar; Malene Krogsgaard-Bording; Helle Østermark-Sørensen; Wulf Rössler; Wolfram Kawohl; Benjamin Mayer; Mike Slade
Journal:  BMC Psychiatry       Date:  2017-01-23       Impact factor: 3.630

5.  Validation of Hindi version of Stages of Recovery Instrument.

Authors:  Sandeep Grover; Neha Singla; Ajit Avasthi
Journal:  Indian J Psychiatry       Date:  2016 Oct-Dec       Impact factor: 1.759

6.  Optimism and the Psychological Recovery Process Among Informal Caregivers of Inpatients Suffering From Depressive Disorder: A Descriptive Exploratory Study.

Authors:  Claire Coloni-Terrapon; Jérôme Favrod; Aurélie Clément-Perritaz; Isabelle Gothuey; Shyhrete Rexhaj
Journal:  Front Psychiatry       Date:  2020-01-16       Impact factor: 4.157

7.  Mediation of the stigma in the influence of negative symptomatology over recovery in psychosis.

Authors:  Nuria Ordóñez-Camblor; Mercedes Paino; Eduardo Fonseca-Pedrero; Juan Pablo Pizarro-Ruiz
Journal:  Int J Clin Health Psychol       Date:  2021-02-01

8.  Impact of receiving recorded mental health recovery narratives on quality of life in people experiencing psychosis, people experiencing other mental health problems and for informal carers: Narrative Experiences Online (NEON) study protocol for three randomised controlled trials.

Authors:  Stefan Rennick-Egglestone; Rachel Elliott; Melanie Smuk; Clare Robinson; Sylvia Bailey; Roger Smith; Jeroen Keppens; Hannah Hussain; Kristian Pollock; Pim Cuijpers; Joy Llewellyn-Beardsley; Fiona Ng; Caroline Yeo; James Roe; Ada Hui; Lian van der Krieke; Rianna Walcott; Mike Slade
Journal:  Trials       Date:  2020-07-20       Impact factor: 2.279

9.  Development and psychometric properties of a five-language multiperspective instrument to assess clinical decision making style in the treatment of people with severe mental illness (CDMS).

Authors:  Bernd Puschner; Petra Neumann; Harriet Jordan; Mike Slade; Andrea Fiorillo; Domenico Giacco; Anikó Egerházi; Tibor Ivánka; Malene Krogsgaard Bording; Helle Østermark Sørensen; Arlette Bär; Wolfram Kawohl; Sabine Loos
Journal:  BMC Psychiatry       Date:  2013-02-04       Impact factor: 3.630

10.  Measuring mental health recovery: Cross-cultural adaptation of the 15-item Questionnaire about the Process of Recovery in Spain (QPR-15-SP).

Authors:  Jessica Marian Goodman-Casanova; Daniel Cuesta-Lozano; Marta Garcia-Gallardo; Francisco Javier Duran-Jimenez; Fermin Mayoral-Cleries; Jose Guzman-Parra
Journal:  Int J Ment Health Nurs       Date:  2022-03-11       Impact factor: 5.100

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.